Endometriosis is a chronic illness that causes tissue similar to the uterine lining to grow on other organs in the body. This condition can cause severe pain in patients, particularly during periods, sexual intercourse and bowel movements. The inflammatory illness affects about 190 million girls and women of reproductive age around the globe. It has no known cure, with treatment focusing on managing its symptoms.
Now, new research has found that cannabis may help women manage symptoms of endometriosis. For the new study, researchers conducted an analysis of survey responses from 912 adult patients suffering from endometriosis in Switzerland, Austria and Germany. Of these patients, 114 of them admitted to using cannabis to manage the illness, which is known to cause a lot of pain.
The researchers found that most users of marijuana saw improvements in pain and other symptoms. In detail, about 90% saw improvements in their menstrual pain while 91% saw their sleep improve. Additionally, roughly 90% of the respondents reported that cannabis use led to a reduction in their intake of pain meds.
The researchers found that marijuana users were more likely to have tried different pain drugs in the past. Generally, the findings suggested that patients who had used cannabis also experienced serious pain and perceived pain meds to be less effective.
It should be noted that while some respondents did report more fatigue associated with the use of cannabis, side effects were otherwise minimal.
In their report, the researchers explained that women who used marijuana found it to be effective in decreasing symptom intensity. They also found that on average, respondents took roughly nine years to get diagnosed with the condition. This highlights a need for any knowledge gaps associated with endometriosis be filled while also improving access to quality healthcare.
Despite these positive findings, more studies are needed to determine dosage, the best route of administration, CBD/THC ratio, long-term effects of marijuana use and possible side effects.
The study was carried out by a four-person team from the Center of Oncological Surgery’s gynecology department at the Endometriosis Research Center Charité. The researchers included Sylvia Mechsner, Jalid Sehouli, Renata Voltolini Velho and Victoria Jasinski.
In their conclusion, the researchers noted that at the time of their research, the consumption of marijuana was still illegal in Austria, Germany and Switzerland. Medical marijuana in these countries is rarely prescribed due to complicated requirements.
The scientists reported their findings in the “Gynecologic Endocrinology and Reproductive Medicine” journal.
As more studies are conducted on the potential benefits of using marijuana therapeutically, it is likely that more applications for this substance in managing or treating various ailments could emerge, and the mushrooming of entities that manufacture medical cannabis products, such as TerrAscend Cannabis Corp. (TSX: TSND) (OTCQX: TSNDF), will be further justified.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
